Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Dow
US Department of Justice
Medtronic
Federal Trade Commission
Harvard Business School
Chubb
McKesson

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017498

« Back to Dashboard

NDA 017498 describes MICRONASE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the MICRONASE profile page.

The generic ingredient in MICRONASE is glyburide. There are twenty drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the glyburide profile page.
Summary for 017498
Tradename:MICRONASE
Applicant:Pharmacia And Upjohn
Ingredient:glyburide
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017498

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 1, 1984TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG
Approval Date:May 1, 1984TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:May 1, 1984TE:RLD:Yes

Expired US Patents for NDA 017498

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-002 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-002 May 1, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Fuji
Cantor Fitzgerald
Farmers Insurance
Moodys
AstraZeneca
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.